Dolby Laboratories (DLB) Stock Forecast, Price Target & Predictions
DLB Stock Forecast
Dolby Laboratories stock forecast is as follows: an average price target of $90.00 (represents a 16.44% upside from DLB’s last price of $77.29) and a rating consensus of 'Buy', based on 2 wall street analysts offering a 1-year stock forecast.
DLB Price Target
The average price target for Dolby Laboratories (DLB) is $90.00 based on 1-year price targets from 2 Wall Street analysts in the past 3 months, with a price target range of $90.00 to $90.00. This represents a potential 16.44% upside from DLB's last price of $77.29.
DLB Analyst Ratings
According to 2 Wall Street analysts, Dolby Laboratories's rating consensus is 'Buy'. The analyst rating breakdown for DLB stock is 0 'Strong Buy' (0.00%), 1 'Buy' (50.00%), 1 'Hold' (50.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Dolby Laboratories Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Feb 03, 2023 | Rosenblatt Securities | $90.00 | $82.67 | 8.87% | 16.44% |
The latest Dolby Laboratories stock forecast, released on Feb 03, 2023 by Rosenblatt Securities company, set a price target of $90.00, which represents a 8.87% increase from the stock price at the time of the forecast ($82.67), and a 16.44% increase from DLB last price ($77.29).
Dolby Laboratories Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | - |
| Avg Price Target | - | - | - |
| Last Closing Price | $77.29 | $77.29 | $77.29 |
| Upside/Downside | -100.00% | -100.00% | -100.00% |
In the current month, the average price target of Dolby Laboratories stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Dolby Laboratories's last price of $77.29. This month's average price target is down NaN% compared to last quarter, and down NaN% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Jun 07, 2024 | Rosenblatt Securities | Buy | Buy | Hold |
| Apr 26, 2022 | Zacks Investment Research | Hold | Upgrade |
Dolby Laboratories's last stock rating was published by Rosenblatt Securities on Jun 07, 2024. The company gave DLB a "Buy" rating, the same as its previous rate.
Dolby Laboratories Financial Forecast
Dolby Laboratories Revenue Forecast
| Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $290.56M | $298.37M | $375.89M | $334.92M | $278.20M | $289.58M | $334.37M | $351.63M | $285.02M | $286.80M | $319.56M | $389.87M | $271.19M | $246.91M | $351.81M | $291.88M | $298.83M | $302.16M |
| Avg Forecast | $328.75M | $319.46M | $417.96M | $366.38M | $317.47M | $304.51M | $387.20M | $346.14M | $307.94M | $292.85M | $359.43M | $312.16M | $290.20M | $301.66M | $349.85M | $306.56M | $305.23M | $293.92M | $332.51M | $359.38M | $299.95M | $278.79M | $294.29M | $345.33M | $244.43M | $232.61M | $361.35M | $285.81M | $297.55M | $305.29M |
| High Forecast | $336.65M | $327.14M | $428.01M | $375.18M | $325.10M | $311.83M | $401.02M | $347.32M | $307.94M | $293.20M | $359.43M | $321.41M | $295.30M | $308.91M | $358.26M | $313.93M | $305.23M | $293.92M | $332.51M | $359.38M | $299.95M | $278.79M | $294.29M | $345.33M | $244.43M | $232.61M | $361.35M | $285.81M | $297.55M | $305.29M |
| Low Forecast | $323.87M | $314.72M | $411.76M | $360.94M | $312.75M | $299.99M | $377.77M | $345.06M | $307.93M | $292.49M | $359.43M | $303.12M | $280.15M | $297.18M | $344.66M | $302.01M | $305.23M | $293.92M | $332.51M | $359.38M | $299.95M | $278.79M | $294.29M | $345.33M | $244.43M | $232.61M | $361.35M | $285.81M | $297.55M | $305.29M |
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 3 | 1 | 1 | 1 | 3 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 5 | 8 | 5 | 4 | 9 | 6 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.00% | 0.99% | 1.07% | 1.09% | 0.91% | 0.99% | 1.01% | 0.98% | 0.95% | 1.03% | 1.09% | 1.13% | 1.11% | 1.06% | 0.97% | 1.02% | 1.00% | 0.99% |
Dolby Laboratories's average Quarter revenue forecast for Dec 23 based on 3 analysts is $312.16M, with a low forecast of $303.12M, and a high forecast of $321.41M. DLB's average Quarter revenue forecast represents a 7.43% increase compared to the company's last Quarter revenue of $290.56M (Sep 23).
Dolby Laboratories EBITDA Forecast
| Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 3 | 1 | 1 | 1 | 3 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 5 | 8 | 5 | 4 | 9 | 6 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $81.95M | $15.94M | $109.29M | $122.18M | $35.69M | $77.73M | $75.06M | $118.85M | $42.51M | $82.67M | $111.51M | $185.37M | $34.50M | $65.23M | $130.45M | $75.44M | $84.92M | $94.08M |
| Avg Forecast | $87.56M | $85.09M | $111.32M | $97.58M | $84.55M | $81.10M | $103.13M | $92.19M | $82.02M | $78.00M | $74.48M | $83.14M | $77.29M | $80.34M | $67.71M | $137.02M | $88.78M | $85.50M | $61.55M | $104.54M | $87.25M | $81.09M | $71.01M | $100.45M | $71.10M | $67.66M | $136.59M | $83.14M | $86.55M | $88.80M |
| High Forecast | $89.66M | $87.13M | $114.00M | $99.93M | $86.59M | $83.05M | $106.81M | $92.51M | $82.02M | $78.09M | $89.38M | $85.61M | $78.65M | $82.27M | $81.25M | $164.42M | $88.78M | $85.50M | $73.86M | $104.54M | $87.25M | $81.09M | $85.21M | $100.45M | $71.10M | $67.66M | $163.91M | $83.14M | $86.55M | $88.80M |
| Low Forecast | $86.26M | $83.82M | $109.67M | $96.13M | $83.30M | $79.90M | $100.61M | $91.90M | $82.02M | $77.90M | $59.58M | $80.73M | $74.62M | $79.15M | $54.17M | $109.61M | $88.78M | $85.50M | $49.24M | $104.54M | $87.25M | $81.09M | $56.80M | $100.45M | $71.10M | $67.66M | $109.27M | $83.14M | $86.55M | $88.80M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.06% | 0.20% | 1.61% | 0.89% | 0.40% | 0.91% | 1.22% | 1.14% | 0.49% | 1.02% | 1.57% | 1.85% | 0.49% | 0.96% | 0.96% | 0.91% | 0.98% | 1.06% |
3 analysts predict DLB's average Quarter EBITDA for Dec 23 to be $83.14M, with a high of $85.61M and a low of $80.73M. This is 1.45% upper than Dolby Laboratories's previous annual EBITDA (Sep 23) of $81.95M.
Dolby Laboratories Net Income Forecast
| Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 3 | 1 | 1 | 1 | 3 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 5 | 8 | 5 | 4 | 9 | 6 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $9.19M | $31.11M | $95.70M | $79.38M | $27.76M | $39.60M | $36.72M | $80.01M | $44.19M | $54.62M | $76.22M | $135.20M | $26.83M | $67.28M | $88.50M | $48.75M | $43.92M | $39.57M |
| Avg Forecast | $82.10M | $83.07M | $148.75M | $106.25M | $82.14M | $77.06M | $130.76M | $101.84M | $42.98M | $29.46M | $39.01M | $51.28M | $21.39M | $26.84M | $35.47M | $92.17M | $39.56M | $34.47M | $32.24M | $77.66M | $34.43M | $26.95M | $48.92M | $77.75M | $14.46M | $8.01M | $92.56M | $29.69M | $47.23M | $47.67M |
| High Forecast | $84.67M | $85.67M | $153.40M | $109.57M | $84.71M | $79.47M | $143.64M | $107.65M | $44.33M | $30.38M | $46.82M | $51.85M | $22.20M | $27.67M | $42.56M | $110.60M | $39.56M | $34.47M | $38.69M | $77.66M | $34.43M | $26.95M | $58.70M | $77.75M | $14.46M | $8.01M | $111.07M | $29.69M | $47.23M | $47.67M |
| Low Forecast | $80.52M | $81.47M | $145.88M | $104.20M | $80.56M | $75.57M | $114.91M | $96.02M | $42.15M | $28.89M | $31.21M | $50.13M | $20.18M | $26.32M | $28.37M | $73.73M | $39.56M | $34.47M | $25.79M | $77.66M | $34.43M | $26.95M | $39.13M | $77.75M | $14.46M | $8.01M | $74.04M | $29.69M | $47.23M | $47.67M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.43% | 1.16% | 2.70% | 0.86% | 0.70% | 1.15% | 1.14% | 1.03% | 1.28% | 2.03% | 1.56% | 1.74% | 1.86% | 8.40% | 0.96% | 1.64% | 0.93% | 0.83% |
Dolby Laboratories's average Quarter net income forecast for Dec 23 is $51.28M, with a range of $50.13M to $51.85M. DLB's average Quarter net income forecast represents a 458.23% increase compared to the company's last Quarter net income of $9.19M (Sep 23).
Dolby Laboratories SG&A Forecast
| Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 3 | 1 | 1 | 1 | 3 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 5 | 8 | 5 | 4 | 9 | 6 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $157.48M | $155.55M | $157.63M | $142.18M | $147.27M | $144.23M | $182.92M | $159.61M | $152.66M | $136.83M | $137.44M | $129.90M | $136.98M | $121.78M | $149.28M | $147.65M | $135.16M | $137.57M |
| Avg Forecast | $154.16M | $149.81M | $196.00M | $171.81M | $148.87M | $142.79M | $181.57M | $162.32M | $144.40M | $137.33M | $194.34M | $146.38M | $136.08M | $141.46M | $176.68M | $183.86M | $141.15M | $135.92M | $160.62M | $166.19M | $138.71M | $128.92M | $88.21M | $159.69M | $113.03M | $107.57M | $156.13M | $132.17M | $137.60M | $141.18M |
| High Forecast | $157.87M | $153.41M | $200.71M | $175.94M | $152.45M | $146.23M | $188.05M | $162.87M | $144.40M | $137.49M | $233.21M | $150.72M | $138.48M | $144.86M | $212.01M | $220.63M | $141.15M | $135.92M | $192.74M | $166.19M | $138.71M | $128.92M | $105.85M | $159.69M | $113.03M | $107.57M | $187.36M | $132.17M | $137.60M | $141.18M |
| Low Forecast | $151.87M | $147.58M | $193.09M | $169.26M | $146.66M | $140.67M | $177.15M | $161.81M | $144.40M | $137.16M | $155.48M | $142.14M | $131.37M | $139.36M | $141.34M | $147.09M | $141.15M | $135.92M | $128.49M | $166.19M | $138.71M | $128.92M | $70.57M | $159.69M | $113.03M | $107.57M | $124.91M | $132.17M | $137.60M | $141.18M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.16% | 1.10% | 0.89% | 0.77% | 1.04% | 1.06% | 1.14% | 0.96% | 1.10% | 1.06% | 1.56% | 0.81% | 1.21% | 1.13% | 0.96% | 1.12% | 0.98% | 0.97% |
Dolby Laboratories's average Quarter SG&A projection for Dec 23 is $146.38M, based on 3 Wall Street analysts, with a range of $142.14M to $150.72M. The forecast indicates a -7.05% fall compared to DLB last annual SG&A of $157.48M (Sep 23).
Dolby Laboratories EPS Forecast
| Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 3 | 1 | 1 | 1 | 3 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 5 | 8 | 5 | 4 | 9 | 6 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | $0.10 | $0.33 | $1.00 | $0.83 | $0.29 | $0.40 | $0.36 | $0.79 | $0.44 | $0.54 | $0.75 | $1.34 | $0.27 | $0.67 | $0.88 | $0.49 | $0.44 | $0.39 |
| Avg Forecast | $0.85 | $0.86 | $1.54 | $1.10 | $0.85 | $0.80 | $1.35 | $1.05 | $0.45 | $0.30 | $1.01 | $0.53 | $0.22 | $0.28 | $0.68 | $0.48 | $0.41 | $0.35 | $0.52 | $0.80 | $0.35 | $0.28 | $0.46 | $0.80 | $0.15 | $0.08 | $0.90 | $0.30 | $0.48 | $0.49 |
| High Forecast | $0.88 | $0.89 | $1.59 | $1.13 | $0.88 | $0.82 | $1.49 | $1.11 | $0.46 | $0.31 | $1.01 | $0.54 | $0.23 | $0.29 | $0.70 | $0.50 | $0.41 | $0.35 | $0.52 | $0.80 | $0.35 | $0.28 | $0.46 | $0.80 | $0.15 | $0.08 | $0.90 | $0.30 | $0.48 | $0.49 |
| Low Forecast | $0.83 | $0.84 | $1.51 | $1.08 | $0.83 | $0.78 | $1.19 | $0.99 | $0.44 | $0.30 | $1.01 | $0.52 | $0.21 | $0.27 | $0.66 | $0.48 | $0.41 | $0.35 | $0.52 | $0.80 | $0.35 | $0.28 | $0.46 | $0.80 | $0.15 | $0.08 | $0.90 | $0.30 | $0.48 | $0.49 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.45% | 1.19% | 1.48% | 1.71% | 0.72% | 1.13% | 0.69% | 0.99% | 1.25% | 1.96% | 1.64% | 1.68% | 1.82% | 8.17% | 0.98% | 1.61% | 0.91% | 0.80% |
According to 3 Wall Street analysts, Dolby Laboratories's projected average Quarter EPS for Dec 23 is $0.53, with a low estimate of $0.52 and a high estimate of $0.54. This represents a 430.88% increase compared to DLB previous annual EPS of $0.10 (Sep 23).